Document is current
Any future updates will be listed below
-
Authors
Bien-Möller, Sandra https://orcid.org/0000-0002-0603-8953
Weidemeier, Martin E. https://orcid.org/0000-0002-3706-6551
Radke, Josefine
Baldauf, Jörg
Engeli, Stefan
Tzvetkov, Mladen V.
Schroeder, Henry W. S.
- License Information
-
More Information
Article History
Received: 16 July 2024
Revised: 20 November 2024
Accepted: 21 January 2025
First Online: 28 April 2025
Competing interests
: The authors declare no competing interests.
: All three patients provided informed consent for participation in this first-in-human trial investigating the application of meldonium in glioblastoma. The study was conducted in accordance with the principles outlined in the Declaration of Helsinki.
